China-based Uni-Bio Science Group Limited (HKG: 0690) has announced two significant achievements in the medical aesthetics and skincare fields. The company’s recombinant collagen dressing, co-developed with Chongqing Minji Medical Device Co., Ltd., has been granted a Category II device approval by the National Medical Products Administration (NMPA). Concurrently, its in-house developed medical aesthetics product, JiYanTai, has been successfully launched in China.
NMPA Approval for Recombinant Collagen Dressing
Uni-Bio’s recombinant collagen dressing, now approved by the NMPA, is rich in collagen and offers multiple benefits for skincare. The dressing can be used for moisturizing the skin, maintaining skin barriers, and anti-aging purposes, making it a valuable addition to the medical aesthetics market.
Launch of JiYanTai Based on Proprietary Skbrella FN Technology
JiYanTai is developed based on proprietary patents of Skbrella FN (Recombinant Human Fibronectin). Fibronectin is a multifunctional extracellular matrix glycoprotein that plays a crucial role in cell migration, adhesion, proliferation, hemostasis, and tissue repair. The launch of JiYanTai underscores Uni-Bio’s commitment to innovation in medical aesthetics and skincare solutions.-Fineline Info & Tech
